FDA Efforts to Advance Racial and Ethnic Minority Participation in Clinicals Trials
Dr Richardae Araojo serves as the Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA). In this role, RADM Araojo provides leadership, oversight, and direction on minority health and health disparity matters for the Agency. Certain populations are less accepting of generics, but this is changing due to generic drug landscape and insurance coverage. How do we ensure that the product is bioequivalent for all populations?